Notice of Intent to Sole Source – Roche Diagnostics

SOL #: NOI-OD-26-003210Pre-SolicitationSole Source

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

Bethesda, MD

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Laboratory Equipment And Supplies (6640)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 9, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), specifically the Department of Transfusion Medicine (DTM), has issued a Notice of Intent to Sole Source for the procurement of Roche Cobas 5800 Reagents, Controls, and Consumables. This acquisition is for a new diagnostic test being added to DTM's portfolio. No solicitation will be issued, and quotations will not be requested.

Scope of Requirement

The requirement is for various reagents, controls, and consumables compatible with the Roche COBAS® 5800 system. This system has been evaluated and qualified for testing various sample types and must be compatible with DTM's current laboratory information system. Roche Diagnostics is the original manufacturer, and the COBAS® reagents, consumables, and equipment are proprietary, meaning they cannot be interchanged with other manufacturers' instrumentation or reagents.

Contract & Timeline

  • Type: Notice of Intent to Sole Source (Presolicitation)
  • Authority: Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1). This allows for sole source procurement for purchases not exceeding the simplified acquisition threshold when only one source is reasonably available. The acquisition is exempt from FAR Part 6 – Competition Requirements.
  • Set-Aside: None (Sole Source)
  • Published: March 9, 2026
  • Place of Performance: Bethesda, MD

Action Items

This is not a request for quotation. Interested parties may submit comments referencing the notice identifier to Ryssa Nix, Contract Specialist, via email at Ryssa.nix@nih.gov. Comments must be submitted prior to the closing date specified in the announcement, though a specific date is not provided in this notice.

People

Points of Contact

Chris Ryssa NixPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Pre-Solicitation
Posted: Mar 9, 2026
Notice of Intent to Sole Source – Roche Diagnostics | GovScope